Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation.
Antimicrobial resistance
Antimycobacterial
MDR-TB
Pyrrole
SAR
Tuberculosis
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
05 Jul 2022
05 Jul 2022
Historique:
received:
11
03
2022
revised:
16
04
2022
accepted:
18
04
2022
pubmed:
30
4
2022
medline:
26
5
2022
entrez:
29
4
2022
Statut:
ppublish
Résumé
An exploration of the chemical space around a 2,5-dimethylpyrrole scaffold of antitubercular hit compound 1 has led to the identification of new derivatives active against Mycobacterium tuberculosis and multidrug-resistant clinical isolates. Analogues incorporating a cyclohexanemethyl group on the methyleneamine side chain at C3 of the pyrrole core, including 5n and 5q, exhibited potent inhibitory effects against the M. tuberculosis strains, substantiating the essentiality of the moiety to their antimycobacterial activity. In addition, selected derivatives showed promising cytotoxicity profiles against human pulmonary fibroblasts and/or murine macrophages, proved to be effective in inhibiting the growth of intracellular mycobacteria, and elicited either bactericidal effects, or bacteriostatic activity comparable to 1. Computational studies revealed that the new compounds bind to the putative target, MmpL3, in a manner similar to that of known inhibitors BM212 and SQ109.
Identifiants
pubmed: 35486992
pii: S0223-5234(22)00306-3
doi: 10.1016/j.ejmech.2022.114404
pii:
doi:
Substances chimiques
Antitubercular Agents
0
Pyrroles
0
2,5-dimethylpyrrole
MZ3OYF5521
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114404Informations de copyright
Copyright © 2022 Elsevier Masson SAS. All rights reserved.